363 related articles for article (PubMed ID: 12414531)
1. Generation of C5a by phagocytic cells.
Huber-Lang M; Younkin EM; Sarma JV; Riedemann N; McGuire SR; Lu KT; Kunkel R; Younger JG; Zetoune FS; Ward PA
Am J Pathol; 2002 Nov; 161(5):1849-59. PubMed ID: 12414531
[TBL] [Abstract][Full Text] [Related]
2. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of the fifth component of human complement and release of a split product with C5a-like activity by crystalline silica through free radical generation and kallikrein activation.
Governa M; Fenoglio I; Amati M; Valentino M; Bolognini L; Coloccini S; Volpe AR; Carmignani M; Fubini B
Toxicol Appl Pharmacol; 2002 Mar; 179(3):129-36. PubMed ID: 11906242
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.
Strunk RC; Eidlen DM; Mason RJ
J Clin Invest; 1988 May; 81(5):1419-26. PubMed ID: 2966814
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro.
Huber-Lang M; Denk S; Fulda S; Erler E; Kalbitz M; Weckbach S; Schneider EM; Weiss M; Kanse SM; Perl M
Mol Immunol; 2012 Feb; 50(1-2):60-5. PubMed ID: 22244896
[TBL] [Abstract][Full Text] [Related]
6. Generation of complement fragment C5a in milk is variable among cows.
Rainard P; Poutrel B
J Dairy Sci; 2000 May; 83(5):945-51. PubMed ID: 10821569
[TBL] [Abstract][Full Text] [Related]
7. Independent regulation of human neutrophil chemotactic receptors after activation.
Bender JG; Van Epps DE; Chenoweth DE
J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
[TBL] [Abstract][Full Text] [Related]
8. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
Maruo K; Akaike T; Ono T; Okamoto T; Maeda H
J Allergy Clin Immunol; 1997 Aug; 100(2):253-60. PubMed ID: 9275149
[TBL] [Abstract][Full Text] [Related]
9. Variability of biological effects of silicas: different degrees of activation of the fifth component of complement by amorphous silicas.
Governa M; Amati M; Fenoglio I; Valentino M; Coloccini S; Bolognini L; Carlo Botta G; Emanuelli M; Pierella F; Volpe AR; Astolfi P; Carmignani M; Fubini B
Toxicol Appl Pharmacol; 2005 Oct; 208(1):68-77. PubMed ID: 16164962
[TBL] [Abstract][Full Text] [Related]
10. Chemotactic and phagocytic responses of human alveolar macrophages to activated complement components.
Richards SW; Peterson PK; Verbrugh HA; Nelson RD; Hammerschmidt DE; Hoidal JR
Infect Immun; 1984 Feb; 43(2):775-8. PubMed ID: 6693176
[TBL] [Abstract][Full Text] [Related]
11. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
Clark RA; Klebanoff SJ
J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
[TBL] [Abstract][Full Text] [Related]
12. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
13. Biologically active complement (C5)-derived peptides and their relevance to disease.
Perez HD
Crit Rev Oncol Hematol; 1984; 1(3):199-225. PubMed ID: 6241542
[TBL] [Abstract][Full Text] [Related]
14. In vitro activation of rat neutrophils and alveolar macrophages with IgA and IgG immune complexes. Implications for immune complex-induced lung injury.
Warren JS; Kunkel SL; Johnson KJ; Ward PA
Am J Pathol; 1987 Dec; 129(3):578-88. PubMed ID: 2827492
[TBL] [Abstract][Full Text] [Related]
15. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.
Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE
Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020
[TBL] [Abstract][Full Text] [Related]
16. Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.
Nitta H; Murakami Y; Wada Y; Eto M; Baba H; Imamura T
Oncol Rep; 2014 Oct; 32(4):1715-9. PubMed ID: 25050844
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha.
Czermak BJ; Sarma V; Bless NM; Schmal H; Friedl HP; Ward PA
J Immunol; 1999 Feb; 162(4):2321-5. PubMed ID: 9973510
[TBL] [Abstract][Full Text] [Related]
18. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of human polymorphonuclear leukocyte adherence to plastic and endothelium by phorbol myristate acetate. Comparison with human C5a.
Webster RO; Wysolmerski RB; Lagunoff D
Am J Pathol; 1986 Nov; 125(2):369-78. PubMed ID: 3789092
[TBL] [Abstract][Full Text] [Related]
20. Complement fragments, alveolar macrophages, and alveolitis.
Henson PM; McCarthy K; Larsen GL; Webster RO; Giclas PC; Dreisin RB; King TE; Shaw JO
Am J Pathol; 1979 Oct; 97(1):93-110. PubMed ID: 495697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
